Author:
Coler-Reilly Ariella L. G.,Sato Tomoo,Matsuzaki Toshio,Nakagawa Masanori,Niino Masaaki,Nagai Masahiro,Nakamura Tatsufumi,Takenouchi Norihiro,Araya Natsumi,Yagishita Naoko,Inoue Eisuke,Yamano Yoshihisa
Funder
Japan Agency for Medical Research and Development
Ministry of Health, Labour and Welfare
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Neurology (clinical),Pharmacology
Reference35 articles.
1. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 2012;3:388.
2. Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol 2012;84:327–335.
3. Bangham CRM, Araujo A, Yamano Y, et al. HTLV-1-associated myelopathy/tropical spastic paraparesis. Nat Rev Dis Prim 2015;1:15012.
4. Osame M, Igata A, Matsumoto M, et al. HTLV-I-associated myelopathy (HAM), treatment trials, retrospective survey and clinical laboratory findings. Hematol Rev 1990;3:271–84.
5. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;1:1031–1032.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献